2016 - Takeda Pharmaceutical Company
12
YOUR VOICE IN PUBLIC POLICY TO IMPROVE LIVES 2016 ANNUAL REPORT
Transcript of 2016 - Takeda Pharmaceutical Company
YOUR VOICE INPUBLIC POLICY
TO IMPROVE LIVES
2016ANNUAL REPORT
Message from the Chair...........................................................................3
2016 TakPAC by the Numbers.................................................................4
2016 TakPAC Financial Statement..........................................................5
Who Decides Where TakPAC Funds Go?...............................................6
2016 Federal, State and Party Contributions.........................................7
How Did TakPAC Compare to Other Industry PACs in 2016?.............10
TakPAC Commitment to Employees.....................................................11
TABLE OF CONTENTS
Welcome to TakPACIt is my pleasure to share the TakPAC 2016 Annual Report with you.
TakPAC is Takeda’s political action committee or PAC —a fund used to help elect state and federal lawmakers who share our vision to bring innovative medicines to patients. This is a program driven by the voluntary contributions of eligible Takeda employees. TakPAC is a traditional PAC, not a Super PAC, and as such, is the only legal way for Takeda to provide direct support to all federal and many state candidates who under-stand our public policy positions related to pharma-ceutical innovation, the needs of patients we serve, and matters important our industry.
The U.S. government accounts for nearly half of all U.S. healthcare spending, and its policies, legislation, and regulations impact the entire healthcare system. The majority of our country’s policymakers have little to no background in medicine or science. We must educate our elected officials on both sides of the aisle and regularly share with them Takeda’s point of view on issues affecting our products and therapeutic areas.
Takeda, through its Government and External Affairs (GEA) function, helps inform the U.S. debate over healthcare and pharmaceutical innovation at the federal, state and local levels. Within GEA’s frame-work, TakPAC plays a crucial role in these ongoing
debates. TakPAC directly supports, in a bipartisan manner, political candidates who understand the importance of the work the biopharmaceutical industry does every day, and helps create an environment where the needs of our patients and our industry can be heard.
Because of the important role of TakPAC in ouradvocacy efforts, Takeda and GEA want you to be fully informed about TakPAC’s mission and activities. This report provides a complete accounting of TakPAC’s financial performance in 2016, as well as the state and federal candidates and committees that were supported. Our objective is to ensure you know not only who we supported and by how much, but how candidate support decisions are made, who makes them, and why. TakPAC is committed to full transparency and good stewardship of all donations made by employees.
On behalf of the entire TakPAC team, I encourage you to learn more about TakPAC.
Rick Ascroft2016 TakPAC ChairmanSenior Vice President, Managed Markets and Government AffairsTakeda Pharmaceuticals U.S.A., Inc.
MESSAGEFROM THE CHAIR
3
2016TakPAC BY THE NUMBERS
177 ELIGIBLE TAKEDA LEADERSPARTICIPATED IN TakPAC
81%OF TakPAC DONORSCONTRIBUTED THROUGHRECURRING PAYROLLDEDUCTION
$71,667.41
19%RAISED THROUGH VOLUNTARY
EMPLOYEE CONTRIBUTIONS—
INCREASEOVER 2015
$90,50050
CONTRIBUTED TOSTATE & FEDERALCANDIDATES &COMMITTEES
93.5%OF STATE & FEDERALCANDIDATES SUPPORTED BY TakPAC WON THEIR ELECTIONS
4
REVENUECash on Hand (1/1/2016) $ 40,546.58Receipts from Voluntary Employee Donations $ 71,667.41 $ 112,213.99
DISBURSEMENTSFederal Candidates & Political Committees $ 43,000.00Federal Political Committees $ 30,000.00State & Local Candidates $ 17,500.00 Operating Expenses (bank fees) $ 1,733.10
$ 92,233.10
Ending Balance (12/31/16) $ 19,980.89
2016 TakPACFINANCIAL
STATEMENT
5
Criteria TakPAC Uses to Determine Candidates to Support• The candidate’s interest or involvement in the pharmaceutical industry and his or her position on key issues affecting Takeda and our patients.
• The presence of Takeda facilities, employees or major customers in the candidate’s district/state.
• The candidate’s leadership and membership on key committees with jurisdiction over legislative issues affecting Takeda and our patients.
• The candidate’s character, integrity and leadership positions.
• The candidate’s financial need and nature of the opposition.
Political party affiliation or positions on non-business policy issues are not criteria for candidate support.
CHAIR VICE CHAIR TREASURER ASST. TREASURER TEAM MEMBER TEAM MEMBER
RICHARDASCROFTSr. Vice President,Managed Marketsand GovernmentAffairs
LAURACLINEHead, Policy andAdvocacyGovernment andExternal Affairs
HELENGIZASr. Vice Presidentand Chief FinancialOfficerU.S. Business Unit
PATRICKBUTLERHead,U.S. Tax
ANDREWKAPLANVice President,Government and External Affairs
SHELLEYSTEWARTDirector, Federal Government Affairs
WHO DECIDESWHERE TakPAC
FUNDS GO?
6
TakPAC Board of Directors
2016POLITICAL
CONTRIBUTIONS
Federal Contributionsby Party
Candidates Party AmountCaliforniaRep. Scott Peters D $5,000IllinoisRep. Cheri Bustos D $1,000Rep. Danny Davis D $2,500Rep. Robert Dold Jr. R $5,000Rep. Robin Kelly D $1,000Sen. Mark Kirk R $1,500Rep. Peter Roskam R $2,500Rep. John Shimkus R $1,000IndianaRep. Susan Brooks R $1,000MassachusettsRep. Michael Capuano D $5,000Rep. Katherine Clark D $2,500Rep. Joseph Kennedy III D $1,000Rep. Jim McGovern D $1,000Rep. Seth Moulton D $2,500Rep. Richard Neal D $2,500MinnesotaRep. Erik Paulsen R $1,500North CarolinaRep. Patrick McHenry R $2,500OregonSen. Ron Wyden D $1,250WashingtonRep. Cathy McMorris Rodgers R $1,500Sen. Patty Murray D $1,250
Total $43,000
7
Distribution of State and FederalContributions
Federal Political Committees AmountCommittee for Hispanic Causes/Building Our Leadership Diversity PAC (CHC BOLD PAC)
$5,000
National Republican Congressional Committee $15,000New Democrat Coalition PAC $5,000Republican Main Street Partnership PAC $5,000
Total $30,000
2016POLITICAL
CONTRIBUTIONS
8
Candidates Party AmountOhioState Rep. Nickie Antonio D $500State Rep. Heather Bishoff D $500State Sen. Randy Gardner R $500State Sen. Lou Gentile D $500State Rep. Cliff Hite R $500State Rep. Stephen Huffman R $500State Sen. Larry Obhof, Jr. R $500State Rep. Cliff Rosenberger R $1,000State Rep. Fred Strahorn D $1,000TexasState Rep. Carol Alvarado D $500State Rep. Cesar Blanco D $500State Rep. Cindy Burkett R $500State Rep. Garnet Coleman D $500State Rep. Drew Darby R $500State Sen. Juan Hinojosa D $1,000State Sen. Lois Kolkhorst R $1,000State Rep. Eddie Lucio III D $500State Sen. Robert Nichols R $1,000State Sen. Charles Perry R $750State Rep. Four Price R $500State Rep. Eduardo Rodriguez D $500State Sen. Charles Schwertner R $1,000State Sen. Van Taylor R $1,000State Sen. Kirk Watson D $750State Sen. Judith Zaffirini D $1,000State Rep. John Zerwas R $500
Total $17,500
State Contributionsby Party
TakPAC Contribution Limits$5,000 per primary and general election to a federal candidate’s campaign committee.
$15,000 per calendar year to each national party committee, such as the Democratic and Republican national, senatorial and congressional campaign committees.
$5,000 per year to a federal incumbent’s leadership PAC. Leadership PACs may be sponsored by Members of Congress to support other candidates from their political party in order to position themselves for future leadership spots or committee chairmanships. These are separate from a member’s campaign committee.
$5,000 per year to a state or local party committee. Contribution limits for state and local candidates vary by state laws.
2016POLITICAL
CONTRIBUTIONS
9
2016POLITICAL
CONTRIBUTION RANKINGS
Daiichi SankyoEisai
TakedaBaxter
Boehringer IngelheimTeva
AstellasBayer
NovartisBristol-Myers Squibb
Novo NordiskGlaxoSmithKline
AstraZenecaJohnson & Johnson
SanofiMerck
AbbVieAmgen
LillyPfizer
$46,231 $51,433 $71,667 $96,440 $124,084 $128,576 $176,073 $186,301 $211,306 $253,674 $332,328 $380,360 $580,572 $610,078 $652,019 $763,316 $865,410 $884,577 $962,867 $1,515,312
HOW DID TakPAC COMPARE TO OTHER INDUSTRY PACS IN 2016?
10
TakPACCOMMITMENT
TO EMPLOYEES
Takeda U.S. engages at all levels of government to ensure we have a voice in the public policy debates that shape and define our company, affect the medicines we develop and market, and impact our ability to serve patients who need them.
Many issues drive our political activities.Takeda puts patients at the center of everything we do, from our research and development to the launch and sale of products. And rightly so—it is our goal to create value to address the unmet medical needs of patients all over the globe.
Takeda’s U.S. Government and External Affairs (GEA) staff works to educate state and federal elected officials about issues affecting our products and therapeutic areas. GEA also advocates for policies that reflect our patient-centric approach, and to be the voice for patients in public policy discussions on Capitol Hill and in state capitals across the country. Our elected leaders need to know how their decisions and policies will impact the health of patients in their district or state.
Takeda’s GEA team is committed to a transparent TakPAC and providing information to all employees about the public policy issues that impact our company. We believe it is important for everyone at Takeda to understand the impact, positive and negative, that public policy decisions have on our company and the patients we serve.
11
